A role for DNA-mediated charge transport in regulating p53: Oxidation of the DNA-bound protein from a distance by Augustyn, Katherine E. et al.
A role for DNA-mediated charge transport in
regulating p53: Oxidation of the DNA-bound
protein from a distance
Katherine E. Augustyn, Edward J. Merino, and Jacqueline K. Barton*
Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125
Contributed by Jacqueline K. Barton, October 1, 2007 (sent for review September 20, 2007)
Charge transport (CT) through the DNA base pairs provides a
means to promote redox reactions at a remote site and potentially
to effect signaling between molecules bound to DNA. Here we
describe the oxidation of a cell-cycle regulatory protein, p53, from
a distance throughDNA-mediated CT. A consensus p53 binding site
aswell as three DNA promoters regulated by p53were synthesized
containing a tethered DNA photooxidant, anthraquinone. Photo-
induced oxidation of the protein occurs from a distance; introduc-
tion of an intervening CA mismatch, which inhibits DNA-mediated
CT, prevents oxidation of p53. DNA-mediated oxidation is shown
to promote dissociation of p53 from only some promoters, and this
sequence-selectivity in oxidative dissociation correlates with the
biological regulation of p53. Under severe oxidative stress, ef-
fected here through oxidation at long range, p53 dissociates from
a promoter that activates DNA repair as well as the promoter for
the negative regulator of p53, Mdm2, but not from a promoter
activating cell-cycle arrest. Mass spectrometry results are consis-
tent with disulfide bond formation in p53 upon DNA-mediated
oxidation. Furthermore, DNA-boundp53 oxidation is shown in vivo
by up-regulation of p53 and subsequent irradiation in the presence
of a rhodium photooxidant to give a new p53 adduct that can be
reversedwith thiol treatment. This DNA-mediated oxidation of p53
parallels that seen by treating cells with hydrogen peroxide. These
results indicate a uniquemechanismusingDNA-mediated CT chem-
istry by which p53 activity on different promoters may be con-
trolled globally under conditions of oxidative stress.
DNA electron transfer  oxidative stress  redox regulation
The protein p53 is a 393-aa tumor suppressor involved incontrolling cellular pathways that include apoptosis, cell
cycle arrest, and DNA repair (1–6). Functioning as a transcrip-
tion factor controlling the expression of myriad downstream
genes, p53 must distinguish between promoters to regulate
pathways under different cellular pressures, such as hypoxia and
oxidative stress (3). It is no surprise that a protein this crucial to
cellular integrity also is tightly regulated; a critical negative
regulator of p53 function is Mdm2, an E3 ubiquitin ligase that,
when bound to p53, facilitates its degradation (4). How is the
binding of p53 to its different promoters chemically controlled
depending on different cellular stresses? Here we show that the
binding of p53 to specific promoter sequences, including that
encoding theMdm2 gene, can be altered from a distance through
the DNA-mediated oxidation of p53. Hence DNA-mediated
charge transport (CT) is seen to provide a chemical basis to
understand the global regulation of p53 under oxidative stress.
The sequence-specific activation of transcription by p53 de-
pends on its ability to bind to a consensus sequence within the
promoter region. The consensus sequences for p53 consist of two
symmetric response elements PuPuPuC(A/T)(T/A)GPyrPyrPyr
spaced 0- to 13-bp apart (7). Many of the natural promoter
sequences that bind p53 do not have a 100% consensus match.
Conversely, some sequences that share 100% homology with the
consensus sequence do not bind p53 (8). Most p53 mutations
found in human tumors are located in the DNA-binding domain
and involve amino acid residues that contact DNA or are
required for proper folding (9, 10). The strength of p53 binding
to a specific DNA sequence also is inf luenced by post-
translational modification (8) and the redox state of the protein
(11–13). In particular, oxidative conditions decrease the specific
affinity of p53 for certain promoters. In the DNA binding
domain are 10 conserved cysteines, of which 3 are involved in
zinc coordination (9). Interestingly, cysteine 277, seen hydrogen-
bonded to the consensus sequence in the crystal structure of p53
bound to DNA, has been proposed to undergo disulfide bond
formation with cysteine 275, which would alter p53 binding to
DNA in a redox-sensitive manner (14). Cysteines 141 and 135,
only 3.8-Å apart, also are in close proximity to the DNA bases
and represent additional targets for disulfide bond formation
that could alter DNA binding.
Oxidative damage to DNA arising at long range through
DNA-mediated CT now has been demonstrated by using a
variety of pendant, distally bound photooxidants (15–19). We
have shown that oxidative damage to DNA can occur at least
200-Å away from the tethered oxidant (16). Although this
reaction displays a shallow distance dependence, it is exquisitely
sensitive to perturbations in the intervening base-pair stack;
DNA binding proteins, intervening mismatches, and base lesions
can serve to attenuate charge migration (20). This sensitivity of
DNA CT to stacking perturbations has led to its application in
developing novel electrochemical sensors (21, 22). DNA CT also
has been proposed to play a biological role in the detection of
base lesions by DNA repair proteins (23). Moreover, long-range
oxidative DNA damage through CT has been demonstrated to
occur within nucleosomes and within the cell nucleus (24, 25).
DNA CT furthermore can be harnessed to promote a variety of
redox reactions on DNA triggered from a distance. We have
shown that thymine dimers in DNA can be repaired at long range
through DNA-mediated CT (26). Most recently, we have deter-
mined that DNA CT can be used to promote the formation of
disulfide bonds from thiols incorporated into theDNA backbone
(27). It is this chemistry, triggered from a distance, that we
considered also might be useful in promoting reactions of
proteins bound to DNA. Because p53 contains cysteine residues
in close proximity within theDNAbinding domain, we wondered
whether we could selectively oxidize the DNA-bound protein
and, in so doing, alter DNA binding through long-range CT. This
chemistry from a distance, mediated by DNA, then would
provide a completely novel mechanism to globally regulate p53
binding. Fig. 1 schematically illustrates this general chemistry.
Results and Discussion
Photooxidation of p53 Bound to Different DNA Sequences. To test
whether DNA-bound p53 could be oxidized from a distance, a
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100% consensus match sequence (LC-Con-1) and the analogous
sequence (AQ-Con-1) containing the potent photooxidant an-
thraquinone (AQ) were synthesized, and binding by p53 was
determined by electrophoretic mobility-shift assay (Fig. 2). After
incubating p53 with LC-Con-1 or AQ-Con-1, the sample was
either irradiated at 350 nm for 30 min to activate AQ or left in
the dark as a control. After native gel electrophoresis, the
amounts of p53 bound to AQ-Con-1 and LC-Con-1 with and
without irradiation were compared. As can be seen in Fig. 2, the
amount of p53 bound to LC-Con-1 does not change with
irradiation, nor does functionalization of the consensus DNA
with AQ (AQ-Con-1) in the absence of light affect p53 binding.
However, when AQ-Con-1 is irradiated, promoting DNA-
mediated oxidation, the amount of bound DNA decreases;
DNA-mediated CT appears to promote the dissociation of p53.
To investigate further that the decrease in binding with photo-
activation of AQ is the result of a DNA-mediated process, we
examined binding to an AQ-functionalized consensus DNA
duplex containing a single CA mismatch intervening between
the photooxidant and the p53 binding site (AQ-MM). It has been
demonstrated extensively that single base mismatches perturb
DNA-mediated CT (20, 21). As can be seen also in Fig. 2, little
change is observed as a function of irradiation with the mismatch
intervening; the introduction of a mismatch prevents p53 disso-
ciation. Note that no evidence of p53 cross-linking was found.
These results are consistent with p53 dissociation being the
consequence of DNA-mediated CT through the base-pair stack.
To test natural promoter sequences, promoter regions for the
p21 (LC-p21 and AQ-p21) and Gadd45 (LC-G45 and AQ-G45)
genes, were synthesized with and without an AQ photooxidant.
The p21 gene encodes a cyclin-dependent kinase inhibitor,
WAF1, involved in G1 arrest whereas Gadd45 encodes a protein
active in G2 arrest as well as in DNA repair (5, 6). The two
promoter sequences differ in four positions within the recogni-
tion element but have similar binding affinities (28). After
incubation with p53, samples were irradiated or left in the dark,
and binding of p53 to the two promoters was examined. Fig. 3
shows that although p53 dissociates from the Gadd45 sequence
as a function of irradiation, the binding of p53 remains relatively
unaltered on the p21 promoter under analogous conditions.
Fig. 1. Schematic illustration ofDNA-mediatedCT to promote oxidation and
dissociation of p53 (red), where AQ serves as the tethered, distally bound
photooxidant. Upon photoexcitation, the AQ injects an electron hole into the
DNA duplex that can migrate through the DNA to p53, resulting in protein
oxidation. This oxidation can induce a conformational change in the DNA-
binding domain of p53, promoting its dissociation from the DNA.
Fig. 2. Oxidation of p53 bound to the consensus sequencewith andwithout
a base-pair mismatch. The electrophoretic mobility-shift assay (Upper Left) is
shown as an autoradiogram after electrophoresis under nondenaturing con-
ditions of LC-Con-1, the consensus sequence without appended oxidant,
LC-MM, the consensus sequence containing a CA mismatch, AQ-Con-1, the
consensus sequencewith tethered AQ and AQ-MM, themismatch-containing
consensus sequencewith tethered AQboth in the absence of irradiation (DC),
and with irradiation for 30 min at 350 nm (350) in the presence of p53. The
sequences for AQ-Con-1 andAQ-MMare shown (Lower) with the p53 binding
site boxed and the site of 32P end-labeling indicated by an asterisk; the CA
mismatch is highlighted in red. A bar graph (Upper Right) quantifying the
percentage change in binding with irradiation for the different sequences
with andwithout the AQphotooxidant also is shown. The percentage change
in binding was determined as a ratio of the percentage of bound DNA in the
dark control to that in the irradiated sample. Error bars reflect the standard
deviations obtained frommultiple trials. Samples contained 0.125Mduplex,
0.5 M p53, 5 M dAdT, 0.1% np-40, 0.1 mg/ml BSA in 20 mM TrisCl (pH 8),
20% glycerol, 100 mM KCl, and 0.2 mM EDTA.
Fig. 3. Sequence-selectivity in photooxidation of p53. Shown (Upper Left) is
an autoradiogram for the gel-shift assay after electrophoresis under nonde-
naturing conditions of LC-p21, AQ-p21, LC-G45, and AQ-G45 both without
irradiation (DC) andwith irradiation for 30minat 350nm (350) in thepresence
ofp53. The sequencesofAQ-p21andAQ-G45with thep53binding sitesboxed
are indicated (Lower), where the asterisk indicates the site of 32-P end-
labeling. A bar graph (Upper Right) quantifying the percentage change in
bindingwith irradiation for the different sequences with andwithout the AQ
photooxidant also is shown. The percentage change in binding was deter-
mined as a ratio of the percentage of bound DNA in the dark control to that
in the irradiated sample. Error bars reflect the standard deviations obtained
from multiple trials. Samples contained 0.125 M duplex, 0.5 M p53, 5 M
dAdT, 0.1% np-40, 0.1 mg/ml BSA in 20 mM TrisCl (pH 8), 20% glycerol, 100
mM KCl, and 0.2 mM EDTA.
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Therefore, this oxidative dissociation, despite being triggered
from distance, is sequence-selective.
The fact that only certain sequences are affected by long-range
oxidation provides a mechanism through which oxidized p53 can
discriminate among promoters depending on cellular conditions.
Oxidative stress can lead to the generation of guanine radicals
throughout the genome through DNA-mediated CT. The ob-
servation that binding to the p21 promoter is not strongly
affected by DNA-mediated CT suggests that, with oxidative
stress, this cell-cycle arrest protein still is transcribed. In contrast,
based on these results, the transcription of Gadd45 would be
expected to be down-regulated; with substantial generation of
guanine radicals, the DNA would be damaged beyond the
capabilities of repair. In fact, it has been shown that, depending
on cellular stress, these two genes are differentially activated by
p53; with ionizing radiation, binding of p53 to the p21 promoter
is maintained, but dissociation occurs from the Gadd45 pro-
moter (14, 29).
The E3 ubiquitin ligase Mdm2 is a crucial protein involved in
the regulation of p53 activity (4). Binding of Mdm2 to p53
promotes its ubiquitination and signals for its transport to the
cytoplasm where it is degraded. In turn, p53 transcribes the
Mdm2 gene, resulting in a negative feedback loop for p53
transcriptional activity. Understandably, conditions of severe
oxidative stress are known to lead to decreased transcription of
Mdm2, ensuring higher levels of p53 and therefore increased
transcription of proapoptotic genes (30).
A 150-bp fragment containing the human Mdm2 promoter
(LC-MDM2) was constructed as was an analogous fragment with
tethered AQ (AQ-MDM2). LC-MDM2 and AQ-MDM2 se-
quences were incubated with p53 and either irradiated at 350 nm
for 45 min or left in the dark. The fraction of bound DNA is
found to decrease as a function of irradiation for AQ-MDM2,
where long-range CT occurs, but remains relatively unaltered for
LC-MDM2, the fragment lacking the photooxidant (Fig. 4).
Increasing the extent of irradiation results in increased dissoci-
ation of p53 from the Mdm2 promoter, as can be seen in an
irradiation time course monitored by gel-shift assay. Thus, it
appears that the dissociation of p53 can be triggered by photo-
induced DNA CT with the photooxidant bound 60 Å away.
Importantly, this result supports the idea that, under conditions
of oxidative stress, where p53 is essential, its level may be
regulated through DNA-mediated oxidation, which, in turn,
leads to the inhibition of the transcription of its negative
regulator. It should be emphasized that, in response to oxidative
stress, the down regulation of the p53–Mdm2 interaction already
has been specifically demonstrated (31); these results provide a
chemical mechanism for that regulation.
Mass Spectrometry Supports the Oxidation of DNA-Bound p53. To
confirm that the dissociation of p53 from certain DNA se-
quences is caused by chemical oxidation of the protein, we
analyzed peptides resulting from a tryptic digest of p53 after
irradiation in the presence of AQ-Con-1. Digestion with trypsin
results in multiple peptide fragments, one of which contains
cysteine 141, a residue located near the DNA binding region of
the protein. This fragment, with a mass of 1,854 Da, is detected
in the absence of irradiation and corresponds to a fragment with
cysteine 141 in the reduced state (Fig. 5). After 3 h of irradiation
at 350 nm of AQ-Con-1 in the presence of p53, however, this
peak is lost. A likely explanation is that DNA-mediated oxida-
tion promotes formation of a disulfide bond between cysteine
141 and the nearby cysteine 135 (associated with another tryptic
peptide) that yields a much larger Mr fragment after trypsin
digestion; cysteine, in fact, has the lowest oxidation potential of
all of the residues and is significantly lower than guanine. That
disulfide bond formation occurs specifically with DNA-mediated
oxidation is supported by reappearance of the 1,854-Mr fragment
with the addition of DTT (data not shown); this reversal is not
quantitative. It is noteworthy that the 1,854-Mr fragment addi-
tionally contains a tryptophan, a residue that also may be easily
oxidized in an electron transfer reaction (32). However, trypto-
phan oxidation would be expected to yield a fragment of1,870,
which we do not observe. Oxidation of cysteines 275 and 277 had
earlier been proposed as a possible redox regulatory switch
associated with p53 binding (14). Trypsin digestion of p53 also
leads to two fragments withMrs of 1,708 and 1,709, one of which
contains both cysteine 275 and 277.We could not reliably resolve
these peaks from one another and from the cysteine 275–277
disulfide product. It therefore is difficult to determine whether
cysteines 275 and 277 also undergo oxidation; certainly other
oxidation products that we cannot resolve are possible. None-
theless, the specific changes in fragmentation pattern we observe
with irradiation, particularly the reversible loss of the 1,854-Mr
Fig. 4. Oxidation of p53 bound to theMdm2 promoter. The gel-shift assay (Upper Left) shows an autoradiogram after electrophoresis under nondenaturing
conditions of LC-MDM2, the sequencewithout appendedoxidant andAQ-MDM2, the sequence containing a tetheredAQboth in the absence of irradiation (DC)
andwith irradiation for 45min at 350nm (350) in thepresenceof p53. Lanesmarkedp53 contain onlyDNA.Quantificationof thepercentage change in binding
also is shown in a bar graph (Upper Center), where the error bars reflect standard deviations from multiple trials. A time course for p53 dissociation from
AQ-MDM2 also is shown (Upper Right) as a function of irradiation. TheMdm2 sequence tethered with AQ is indicated (Lower) (the complementary 32P-labeled
strand is not shown), where the p53 binding sites are highlighted in red and the primers used are underlined. Samples contained 0.125 Mduplex, 0.5 Mp53,
5 M dAdT, 0.1% np-40, 0.1 mg/ml BSA in 20 mM TrisCl (pH 8), 20% glycerol, 100 mM KCl, and 0.2 mM EDTA.
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fragment, establish clearly that DNA-bound p53 is chemically
changed consistent with disulfide bond formation. Photoactiva-
tion of the tethered AQ therefore leads to oxidation of the
DNA-bound protein from a distance.
Photooxidation of p53 in Vivo with a Rhodium Intercalator. To
examine directly whether p53 is oxidized in vivo as a result of
DNA-mediated oxidation, we carried out photooxidation studies
on HCT116 cells by using [Rh(phi)2bpy]3 (phi  9,10-
phenanthrenequinone diimine). This rhodium complex, which
binds DNA by intercalation, was the first photooxidant used in
establishing long-range oxidative DNA damage by DNA-
mediated CT (15). We also have found that, as with AQ,
photoactivation of the DNA-tethered rhodium complex can
promote oxidation of DNA-bound p53 (data not shown). Im-
portantly, this Rh complex also has been used in demonstrating
oxidative DNA damage by CT in HeLa cell nuclei (25). There-
fore, to test for DNA-mediated oxidation of p53 in vivo, HCT116
cells were treated with cisplatin to up-regulate p53 (33), incu-
bated with the rhodium complex for different lengths of time,
and photolyzed. After protein denaturation and SDS/PAGE
analysis of total cellular protein, changes to p53 were analyzed
byWestern blotting analysis. As can be seen in Fig. 6, the banding
pattern of p53 remains relatively unaltered when the cells are
irradiated without rhodium. However, when cells are incubated
with rhodium and light to initiate the photooxidation reaction,
a modified p53 band is clearly apparent above the parent band
at long rhodium incubation times. Furthermore, when the oxi-
dized protein samples are treated with 2-mercaptoethanol, a
reagent that disrupts disulfide bonds, the modified p53 adduct is
reversed. The ability to reversibly form the p53 adduct supports
the hypothesis of DNA-mediated disulfide bond formation in the
regulation of p53.
To ensure that the visualized p53 oxidation product is general
and not specific to Rh treatment, hydrogen peroxide also was
used as an oxidant in HeLa cells in parallel with Rh. As observed
with HCT116 cells, irradiation without rhodium or the presence
of rhodium but without irradiation causes no change in the p53
banding pattern of HeLa cells. However, addition of the rhodium
photooxidant and irradiation leads to a lower-mobility oxidation
product (Fig. 7). Importantly, analogous changes in p53 are
evident on addition of 10 mM hydrogen peroxide to the HeLa
cells and to a comparable level as to cells treated with rhodium
and irradiated. Because the rhodium photooxidant is known to
promote both long-range oxidative DNA damage in cell nuclei
at comparable high concentrations and the DNA-mediated
oxidation of p53 in vitro, these chemical changes to p53 seen in
vivo with rhodium photoactivation likely reflect p53 oxidation at
long range through DNA-mediated CT. Moreover, this DNA-
mediated oxidation appears to effect the same changes in p53 as
Fig. 6. Reversible oxidation of p53 from HCT116 cells visualized by Western
blottinganalysis. After treatmentofHCT116 cellswith cisplatin toup-regulate
p53, cells were incubated with different concentrations of the rhodium pho-
tooxidant for either 1 h or overnight and irradiated with a solar simulator.
Cellular protein was analyzed by SDS/PAGE followed by Western blotting
analysis. Cells irradiated without rhodium show no p53 adduct bands. Over-
night incubation of irradiated cells with either 10 or 25 M [Rh(phi)2bpy]3
lead to a new, lower-mobility p53 adduct (red arrowhead, upper gel). Addi-
tion of 2-mercaptoethanol removes the oxidation-dependent p53 adduct
(lower gel).
Fig. 7. Western blotting analysis of oxidized p53 derived from HeLa cells.
Cells were incubated with hydrogen peroxide for 30 min at 37°C (no irradia-
tion) or with [Rh(phi)2(bpy)]3 for 30 min at 37°C and then irradiated with a
solar simulator (UV cut-off filter 345 nm). Total protein was analyzed by
SDS/PAGE followed by Western blotting with anti-p53 antibody and a fluo-
rescent secondary antibody. Cells irradiated without rhodium, or in the pres-
ence of rhodium but without irradiation, show little change in the p53
banding pattern. However, incubation with 70 M rhodium with irradiation
or hydrogen peroxide yields a change in the p53 profile with a new, lower-
mobility band as indicated by an arrowhead.
Fig. 5. MALDI-TOF mass spectrometry of a p53 tryptic digest after incubation with AQ-Con-1 without (DC) or with (IR) 3 h of irradiation at 350 nm. Samples
contained 0.3 Mduplex and 1.2 Mp53 in 20 mM TrisCl (pH 8), 20% glycerol, 100 mM KCl, and 0.2 mM EDTA. The fragment with a mass of 1,854 corresponds
to the fragment TCPVQWVDSTPPPGTR containing cysteine 141.
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does the oxidative stress associated with treatment of cells with
peroxide. Significantly, then, these experiments illustrate that
oxidative stress mediated through DNA can impart a cellular
damage response that leads to oxidation of p53.
Implications. The activation and functions of p53 are exquisitely
sensitive to the cellular environment. Indeed, increasing levels of
oxidative stress can cause p53 to transcribe either proapoptotic
or antiapoptotic genes, depending on cellular pressures, thus
allowing the cell either to survive and undergo repair under
conditions of low stress, or undergo apoptosis under conditions
of high stress (34). Our results provide a chemical basis to
understand these opposing biological responses. The oxidation
of DNA-bound p53 from a distance, generated by photooxida-
tion in our experiments and presumably through charge migra-
tion among guanine radicals within the cell, is sequence-
selective, requiring the intimate association of p53 with DNA to
promote charge transfer from the DNA and protein oxidation.
Without specific protein/DNA interaction, p53 oxidation and
subsequent dissociation from the DNA does not occur. Hence
DNA-mediated CT, reflecting the extent of oxidative stress in
the cell, can provide a general route at long range to regulate p53
binding to different promoters.
Methods
DNA Synthesis. The consensus sequence with and without a
mismatch, oligonucleotides containing the p21 and GADD45
promoter region, as well as the primers for the Mdm2 sequence
were synthesized on an ABI 394 DNA synthesizer using standard
phosphoramidite chemistry. Sequences not containing AQ were
synthesized with the trityl group intact and were deprotected and
cleaved from the resin in NH4OH overnight at 60°C. The
oligonucleotides were subsequently purified by HPLC before
and after trityl group removal in 80% acetic acid and charac-
terized by MALDI-TOF mass spectrometry. In synthesizing
strands containing the AQ photooxidant, including the primer
for Mdm2, an AQ derivative [AQ-2-carboxylic acid (2-
hydroxyethyl) amide], AQ-1 was used, which was converted into
its respective phosphoramidite and incorporated onto the 5 end
of the sequence with a 15-min coupling time (35). Strands were
cleaved from the resin and deprotected in NH4OH at 60°C
overnight. AQ-DNA was purified once by HPLC and charac-
terized by MALDI-TOF mass spectrometry. The oligonucleo-
tides were quantified by using UV-visible spectroscopy and
annealed to their respective duplexes by heating equal moles of
complementary strands to 90°C for 5 min and slow-cooling to
ambient temperature in a buffer containing 5 mM sodium
phosphate and 50 mM NaCl, pH 7. The resulting duplexes were
purified on a 10% native acrylamide gel at 4°C to remove excess
single-strand. The desired duplex band was excised from the gel
by UV shadowing and eluted into 0.1Qiagen buffer over night
at 4°C. TheDNA then was ethanol-precipitated and resuspended
in a buffer containing 5 mM sodium phosphate and 50 mM
NaCl, pH 7.
The 150-bp duplex containing the humanMdm2 promoter was
constructed from a HeLa DNA template, and primers were
synthesized as described above for standard PCR amplification.
The primers used were 5-GCTTTTCCTCTTGAGCTG-
GTC-3 (forward) or the AQ-tethered analogue and 5-
CGTGCCCACAGGTCTACC-3 (reverse). After incubation at
95°C for 4.5 min, 40 cycles were performed as follows: 94°C for
30 s, 55°C for 1 min, and 72°C for 30 s. The PCR product was
purified by using a QIAquick PCR purification kit (Qiagen),
desalted with a microbiospin-6 chromatography column (Bio-
Rad), and quantified by agarose gel electrophoresis running a
1-kb ladder standard for comparison. DNA strands were labeled
at the 5 end with -32P	ATP and polynucleotide kinase, and
excess ATP was removed by using a microbiospin-6 chromatog-
raphy column (Bio-Rad). A small amount of the labeled duplex
was mixed with a known concentration of cold duplex.
Gel Mobility-Shift Assay. Human p53 used in binding experiments
was purchased from Protein One. Protein was allowed to bind to
the DNA by incubating 0.5 M p53 with 0.25 M labeled duplex
in the presence of 5 M poly dAdT (Amersham Pharmaceuti-
cals), 0.1% np-40, 0.1 mg/ml BSA (New England Biolabs) in 20
mM TrisCl (pH 8), 20% glycerol, 100 mM KCl, and 0.2 mM
EDTA for 1 h at ambient temperature. The samples subse-
quently were either irradiated at 350 nm for 30 or 45 min by using
a 1,000-W Hg/Xe lamp with a 320-nm long pass filter and
monochromator or stored in the dark before gel loading. Sam-
ples containing the Mdm2 promoter complexed with p53 were
loaded onto a 4–20% gradient acrylamide gel (Bio-Rad) in 0.3%
TBE with 0.1% Triton-X, whereas those containing the consen-
sus sequence, p21, or GADD45 promoters were run on an 8%
acrylamide gel. The gradient gels were electrophoresed for 3 h
at 50 V at 4°C, vacuum-dried, and imaged by using a Storm 820
phosphoimager (Molecular Dynamics/GE Healthcare), whereas
the 8% gels were electrophoresed for 1.5 h at 50 V at 4°C and
directly imaged as described above. The fraction of bound DNA
was quantified by using ImageQuant 5.2. Each experiment was
performed at least two times, and the resulting quantifications
were averaged.
Mass Spectrometry of Oxidized p53. Samples containing p53 (1.2
M) were incubated with 0.3 M AQ-Con-1 for 1 h in 20 mM
TrisCl (pH 8), 20% glycerol, 100 mM KCl, and 0.2 mM EDTA.
The samples then were either irradiated at 350 nm on the
1,000-W Hg/Xe lamp for 3 h or stored in the dark. The samples
were digested with 0.4 g of trypsin (Promega) at 37°C over-
night. Digestion was quenched with 4 l of acetic acid. The
resulting peptides were concentrated and desalted with a C-18
zip tip (Millipore) and mixed with an -Cyano matrix. Samples
were analyzed by using a Voyager De-Pro MALDI (PerSeptive
Biosystems) mass spectrometer and calibrated against Se-
quazyme standards.
p53 Oxidation in Vivo. Oxidation of HCT cells was carried out by
incubating 1 million cells with cisplatin containing complete
RPMI 1640 medium (10-cm2 culture flask, 5 ml of medium, 1 h
at 37°C, 0.75 mg/ml cisplatin). After two washes with PBS,
complete RPMI 1640 medium, with [Rh(phi)2bpy]3 where
appropriate, was added. After incubation with [Rh(phi)2bpy]3,
cells were washed and resuspended in 2 ml of PBS. Rh-
containing samples then were irradiated by using a 1,000-W
Orion Solar Simulator for 30 min (the cell culture flask elimi-
nates wavelengths below 350 nm). PBS was removed, and 350 l
of mammalian protein extraction reagent with protease inhibi-
tors (Pierce) was added. Protein samples were centrifuged, and
an equal volume of Laemmli sample buffer was added and
heated to 95°C for 5 min. Samples with 2-mercaptoethanol
contained 150 mM.
Experiments with HeLa cells (5 million) were treated with
trypsin and washed twice with PBS. Cells were resuspended in
50 l of PBS, and an appropriate concentration of oxidant was
added (see Fig. 7); the cells were incubated at 37°C for 30 min.
Rh-containing samples then were irradiated by using the solar
simulator outfitted with a UVB/UVC-blocking filter and a glass
filter that eliminates wavelengths 345 nm for 30 min and were
prepared similarly to the HCT116 cells.
Total cellular protein samples were electrophoresed on a 10%
TrisHCl gel. The gel was transferred via electroblotting to a
poly(vinylidene dif luoride) membrane. The membrane was
blocked for 1 h by incubation in a 5% milk/Tris-buffered saline
Augustyn et al. PNAS  November 27, 2007  vol. 104  no. 48  18911
BI
O
CH
EM
IS
TR
Y
CH
EM
IS
TR
Y
with Tween solution (TBS-T). The membrane was washed with
TBS-T followed by an anti-p53 antibody (sc-126; Santa Cruz
Biotechnologies) and incubated overnight at 4°C. After several
washes with TBS-T, the membrane was incubated with Alexa
Fluor 680 goat anti-mouse IgG (Molecular Probes) for 1 h in
TBS-T with 0.01% SDS at room temperature. After several
washes, the membrane was imaged with a 700-nm filter Li-Cor
imaging system.
We thank L. Hsieh-Wilson for assistance with electroblotting. We also
thank the National Institutes of Health (Grant GM49216) for their
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